The way that this RNPV DCF works is that the $6.19 intrinsic value is the fair value today, with 50% risk adjusted.
So if successful, and IXC go it alone, it will actually be $12.38 post Phase III success and FDA approval
So is to say, without risk adjusting for the phase III risk, we are looking at $12.38.
Hope that helps!
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
9.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.763M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5 | 9.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.7¢ | 9000 | 1 |
View Market Depth
| Last trade - 16.21pm 14/07/2025 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable